期刊文献+

^18F-FDG PET/CT在恶性淋巴瘤诊治中的应用进展 被引量:1

原文传递
导出
摘要 18-氟脱氧葡萄糖正电子断层成像术(^18F-FDGPET)是一种功能成像技术。^18F-FDGPET/CT将^18F—FDGPET与CT融合,既提供病灶的代谢信息,还能够准确定位病变,提高了诊断的敏感性和特异性,广泛应用于恶性淋巴瘤的治疗前分期、治疗中期评估、治疗结束后疗效评价和造血干细胞移植。
作者 应志涛 朱军
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第4期340-342,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献28

  • 1Raanani P,Shasha Y,Perry C. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era[J].Annals of Oncology,2006,(1):117-122.doi:10.1093/annonc/mdj024.
  • 2Schaefer NG,Hany TF,Taverna C. Non-Hodgkin lymphoma and Hodgkin disease; coregistered FDG PET and CT at staging and restaging do we need contrast-enhanced CT[J].Radiology,2004.823-829.
  • 3周莉莉,王椿,赵晋华,颜式可,高彦荣,蔡琦,姜杰玲,万理萍,杨隽,卫菊,赵旻,白海涛.^18氟-氟代脱氧葡萄糖-正电子发射计算机断层显像在淋巴瘤分期和疗效评价中的作用[J].中华血液学杂志,2009,30(4):233-236. 被引量:9
  • 4Hutchings M,Loft A,Hansen M. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma[J].Haematologica,2006.482-489.
  • 5Casulo C,Maragulia J,Zelenatz A. FDG-PET in the staging and prognosis of T-cell lymphoma[J].Annals of Oncology,2011.160.
  • 6Pelosi E,Penna D,Douroukas A. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma:results from a large multicentre study[J].O J Nucl Med Mol Imaging,2011.469-475.
  • 7张旭,樊卫,林晓平,梁培炎,张伟光,胡莹莹.FDG-PET/CT对弥漫大B细胞淋巴瘤骨髓浸润诊断价值的探讨[J].中华血液学杂志,2008,29(12):832-835. 被引量:8
  • 8Mittal BR,Manohar K,Malhotra P. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging[J].Leukemia and Lymphoma,2011.2111-2116.
  • 9Chen YK,Yeh CL,Tsui CC. F-18 FDG PET for evaluation of bone marrow involvement in non-Hodgkin lymphoma;a meta-analysis[J].Clinical Nuclear Medicine,2011.553-559.
  • 10Spaepen K,Stroobants S,Dupont P. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([F] FDG) after first-line chemotherapy in non-Hodgkin's lymphoma:is[18F] FDG-PET a valid alternative to conventional diagnostic methods[J].Journal of Clinical Oncology,2001.414-419.

二级参考文献34

  • 1Bangerter M, Moog F, Buchmann I, et al. FDG PET imaging in patients with lymphoma: a clinical perspective. J Nucl Med, 2001,42:609-610.
  • 2Jerusalem G, Warland V, Najjar F, et al. Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin' s disease and nonHodgkin' s lymphoma. Nucl Med Commun, 1999,20 : 13-20.
  • 3Hwang K, Park CH, Kim HC, et al. Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography. Clin Nucl Med, 2000, 25:789-795.
  • 4Tatsumi M, Kitayama H, Sugahara H, et al. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin' s lymphoma. J Nucl Med, 2001,42:601-608.
  • 5Weihrauch MR, Re D, Bischoff S, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin' s disease. Ann Hematol, 2002, 81 : 20 -25.
  • 6Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood, 2003, 101:3875- 3876.
  • 7Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood, 1998, 91:3340-3346.
  • 8Moog F, Bangrter M, Kotzerke J, et al. 18-F-fluorodeoxyglucosepositron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol, 1998, 16:603-609.
  • 9Pakos EE, Fotopoulos AD, Ioannidis JP. ^18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a Metaanalysis. J Nucl Med, 2005, 46:958-963.
  • 10Schaefer NG, Strobel K, Tavema C, et al. Bone involvement in patients with lymphoma: the role of FDG-PET/CT. Eur J Nucl Med, 2007, 34:60-67

共引文献14

同被引文献13

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部